Fundraiser Atul Phull departs Everstone for UBS
Atul Phull, who spent nine years with India and Southeast Asia-focused private equity firm Everstone Group across two stints, has joined the private funds group at UBS as an executive director.
Phull will focus on distribution, building on the fundraising work he performed for Everstone. He will continue to be based in Singapore, and initially focus on the Southeast Asia and Australia markets,...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.